2011
DOI: 10.1016/j.pnpbp.2011.02.019
|View full text |Cite
|
Sign up to set email alerts
|

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
57
0
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 99 publications
(58 citation statements)
references
References 81 publications
0
57
0
1
Order By: Relevance
“…Alternatively, the current results could be interpreted to indicate that depressive features may be a consequence – rather than a cause – of poorer weight outcomes. Furthermore, it is possible that dysregulated biological pathways, such as immune inflammation 39 , oxidative stress 40,41 , or neuroprogression, could be implicated in both the suppressed weight loss and depressive features. 42 Collectively, these findings might suggest that pre-surgery depression, although common, may not require specific additional clinical intervention prior to gastric bypass unless it is severe enough to interfere with a patient’s ability to adhere to self-care 43 .…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, the current results could be interpreted to indicate that depressive features may be a consequence – rather than a cause – of poorer weight outcomes. Furthermore, it is possible that dysregulated biological pathways, such as immune inflammation 39 , oxidative stress 40,41 , or neuroprogression, could be implicated in both the suppressed weight loss and depressive features. 42 Collectively, these findings might suggest that pre-surgery depression, although common, may not require specific additional clinical intervention prior to gastric bypass unless it is severe enough to interfere with a patient’s ability to adhere to self-care 43 .…”
Section: Discussionmentioning
confidence: 99%
“…The hypothesis that depression is related to neuroinflammation is supported by the antiinflammatory effects of many antidepressants that are used in clinical practice. Tricyclic antidepressants and selective serotonin reuptake inhibitors act through different mechanisms and have different neurotransmitter actions, but all of them have antiinflammatory properties (Lu et al, 2010;Maes et al, 2011). Evidence indicates that the neurodegenerative process in clinical depression occurs through inflammatory pathways (CatenaDell'Osso et al, 2011;Kubera et al, 2011;Maes et al, 2011;Leonard and Maes, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…A significant overlap of brain regions, namely the amygdala and anterior cingulate cortex, implicated in these two conditions provides another possibly explanation [6]. Inflammation appears to be a common pathway implicated in both pain and mood disorders [34,35]. It has been previously conceptualised that both pain and depression are symptoms under the umbrella term "sickness syndrome", a phenomenon seen in the presence of inflammatory cytokines [36].…”
Section: Discussionmentioning
confidence: 99%